首页 > 市场调查报告书 > 製药

个人化医学

市场调查报告书

商品编码

1937063

全球精准医疗市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Precision Medicine Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: 2026年02月05日 | 出版商:

Value Market Research | 英文 227 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录

预计精准医疗市场将从 2025 年的 930.6 亿美元成长到 2034 年的 3,861.6 亿美元，2026 年至 2034 年的复合年增长率为 17.13%。

基因组学、生物技术和数据分析的进步使得针对每位患者的个人化治疗方案成为可能，推动了精准医疗市场的快速成长。随着医疗保健向个人化护理转型，对精准医疗解决方案的需求日益增长，尤其是在肿瘤领域，标靶标靶治疗正在革新癌症治疗。透过整合基因检测和生物标记识别，医疗服务提供者现在可以製定客製化的治疗方案，从而优化治疗效果并最大限度地减少副作用。随着患者和医疗服务提供者寻求更有效、更个人化的医疗解决方案，这一趋势预计将进一步推动市场发展。

技术和数据管理的创新也在塑造精准医疗市场的未来前景。人工智慧 (AI) 和机器学习的兴起提高了分析复杂资料集的能力，从而实现了患者分层并改善了治疗效果。此外，生物资讯学的进步正在促进基因组数据与医疗实践的整合，使医疗服务提供者能够根据患者独特的基因谱做出明智的决策。随着这些技术的不断发展，预计精准医疗的应用将扩展到包括罕见疾病和慢性病在内的各个治疗领域。

此外，随着製药公司和医疗机构意识到个人化医疗的潜力，加大研发投入将对精准医疗市场产生正面影响。学术机构、产业相关人员和监管机构之间的合作对于推动临床试验和成功实施精准医疗策略至关重要。在这种不断变化的环境下，重点预计将转向将精准医疗融入标准治疗方案，而跨学科方法在实现最佳患者疗效方面的重要性也将得到强调。

区域分析
北美市场分析、洞察与预测
- 我们
- 加拿大
- 墨西哥
欧洲市场分析、洞察与预测
- 英国
- 法国
- 德国
- 义大利
- 俄罗斯
- 其他欧洲国家
亚太市场分析、洞察与预测
- 印度
- 日本
- 韩国
- 澳洲
- 东南亚
- 其他亚太国家
拉丁美洲市场分析、洞察与预测
- 巴西
- 阿根廷
- 秘鲁
- 智利
- 其他拉丁美洲国家
中东和非洲市场分析、洞察与预测
- 沙乌地阿拉伯
- UAE
- 以色列
- 南非
- 其他中东和非洲国家

第十三章竞争格局

最新趋势
公司分类
供应链和销售管道合作伙伴（根据现有资讯）
市场占有率和市场定位分析（基于现有资讯）
供应商情况（基于现有资讯）
策略规划

第十四章：公司简介

主要公司的市占率分析
公司简介
- Biocrates Life Sciences
- Tepnel Pharma Services
- Novartis
- Qiagen
- Quest Diagnostics
- Menarini Silicon Biosystems
- NanoString Technologies
- Eagle Genomics
- Pfizer
- Intomics
- Roche
- Teva Pharmaceutical

简介目录

Product Code: VMR11214898

The Precision Medicine Market size is expected to reach USD 386.16 Billion in 2034 from USD 93.06 Billion (2025) growing at a CAGR of 17.13% during 2026-2034.

The precision medicine market is experiencing rapid growth, driven by advancements in genomics, biotechnology, and data analytics that enable tailored treatment approaches for individual patients. As healthcare shifts towards personalized care, the demand for precision medicine solutions is increasing, particularly in oncology, where targeted therapies are revolutionizing cancer treatment. The integration of genetic testing and biomarker identification is allowing healthcare providers to develop customized treatment plans that optimize therapeutic efficacy and minimize adverse effects. This trend is expected to propel the market forward, as patients and providers alike seek more effective and individualized healthcare solutions.

Innovations in technology and data management are also shaping the future of the precision medicine market. The rise of artificial intelligence and machine learning is enhancing the ability to analyze complex datasets, leading to improved patient stratification and treatment outcomes. Additionally, advancements in bioinformatics are facilitating the integration of genomic data into clinical practice, enabling healthcare providers to make informed decisions based on a patient's unique genetic profile. As these technologies continue to evolve, the market is likely to witness a diversification of precision medicine applications across various therapeutic areas, including rare diseases and chronic conditions.

Moreover, the precision medicine market will benefit from increased investment in research and development, as pharmaceutical companies and healthcare organizations recognize the potential of personalized therapies. Collaborative efforts between academic institutions, industry stakeholders, and regulatory bodies will be crucial in advancing clinical trials and ensuring the successful implementation of precision medicine strategies. As the landscape evolves, the focus will shift towards integrating precision medicine into standard care pathways, emphasizing the importance of multidisciplinary approaches in delivering optimal patient outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

Bioinformatics
Big Data Analytics
Drug Discovery
Gene Sequencing
Companion Diagnostics
Others

By Application

CNS
Immunology
Oncology
Respiratory
Others

By End-Use

Diagnostic Companies
Pharmaceutical Companies
Healthcare IT companies
Others
Sequencing by Synthesis
Ion Semiconductor Sequencing
Sequencing by Ligation
Pyrosequencing
Single Molecule Real Time Sequencing
Chain Termination Sequencing
Nanopore Sequencing

By Product

Consumables
Instruments
Services

By Route of Administration

Oral
Injectable

By Drugs

Alectinib
Osimertinib
Mepolizumab
Aripiprazole Lauroxil
Others

COMPANIES PROFILED

Biocrates Life Sciences, Tepnel Pharma Services, Novartis, Qiagen, Quest Diagnostics, Menarini Silicon Biosystems, NanoString Technologies, Eagle Genomics, Pfizer, Intomics, Roche, Teva Pharmaceutical

We can customise the report as per your requriements

Chapter 1. PREFACE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis

Chapter 4. GLOBAL PRECISION MEDICINE MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

4.1. Market Analysis, Insights and Forecast Technology
4.2. Bioinformatics Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Big Data Analytics Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.4. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.5. Gene Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.6. Companion Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PRECISION MEDICINE MARKET: BY APPLICATION 2022-2034 (USD MN)

5.1. Market Analysis, Insights and Forecast Application
5.2. CNS Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. Immunology Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.4. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.5. Respiratory Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PRECISION MEDICINE MARKET: BY END-USE 2022-2034 (USD MN)

6.1. Market Analysis, Insights and Forecast End-use
6.2. Diagnostic Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.4. Healthcare IT companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PRECISION MEDICINE MARKET: BY SEQUENCING BY SYNTHESIS 2022-2034 (USD MN)

7.1. Market Analysis, Insights and Forecast Sequencing By Synthesis
7.2. Ion Semiconductor Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PRECISION MEDICINE MARKET: BY SEQUENCING BY LIGATION 2022-2034 (USD MN)

8.1. Market Analysis, Insights and Forecast Sequencing By Ligation
8.2. Pyrosequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
8.3. Single Molecule Real Time Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
8.4. Chain Termination Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
8.5. Nanopore Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL PRECISION MEDICINE MARKET: BY PRODUCT 2022-2034 (USD MN)

9.1. Market Analysis, Insights and Forecast Product
9.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
9.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
9.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL PRECISION MEDICINE MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

10.1. Market Analysis, Insights and Forecast Route Of Administration
10.2. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
10.3. Injectable Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 11. GLOBAL PRECISION MEDICINE MARKET: BY DRUGS 2022-2034 (USD MN)

11.1. Market Analysis, Insights and Forecast Drugs
11.2. Alectinib Estimates and Forecasts By Regions 2022-2034 (USD MN)
11.3. Osimertinib Estimates and Forecasts By Regions 2022-2034 (USD MN)
11.4. Mepolizumab Estimates and Forecasts By Regions 2022-2034 (USD MN)
11.5. Aripiprazole Lauroxil Estimates and Forecasts By Regions 2022-2034 (USD MN)
11.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 12. GLOBAL PRECISION MEDICINE MARKET: BY REGION 2022-2034(USD MN)

12.1. Regional Outlook
12.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 12.2.1 By Technology
- 12.2.2 By Application
- 12.2.3 By End-use
- 12.2.4 By Sequencing By Synthesis
- 12.2.5 By Sequencing By Ligation
- 12.2.6 By Product
- 12.2.7 By Route Of Administration
- 12.2.8 By Drugs
- 12.2.9 United States
- 12.2.10 Canada
- 12.2.11 Mexico
12.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 12.3.1 By Technology
- 12.3.2 By Application
- 12.3.3 By End-use
- 12.3.4 By Sequencing By Synthesis
- 12.3.5 By Sequencing By Ligation
- 12.3.6 By Product
- 12.3.7 By Route Of Administration
- 12.3.8 By Drugs
- 12.3.9 United Kingdom
- 12.3.10 France
- 12.3.11 Germany
- 12.3.12 Italy
- 12.3.13 Russia
- 12.3.14 Rest Of Europe
12.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 12.4.1 By Technology
- 12.4.2 By Application
- 12.4.3 By End-use
- 12.4.4 By Sequencing By Synthesis
- 12.4.5 By Sequencing By Ligation
- 12.4.6 By Product
- 12.4.7 By Route Of Administration
- 12.4.8 By Drugs
- 12.4.9 India
- 12.4.10 Japan
- 12.4.11 South Korea
- 12.4.12 Australia
- 12.4.13 South East Asia
- 12.4.14 Rest Of Asia Pacific
12.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 12.5.1 By Technology
- 12.5.2 By Application
- 12.5.3 By End-use
- 12.5.4 By Sequencing By Synthesis
- 12.5.5 By Sequencing By Ligation
- 12.5.6 By Product
- 12.5.7 By Route Of Administration
- 12.5.8 By Drugs
- 12.5.9 Brazil
- 12.5.10 Argentina
- 12.5.11 Peru
- 12.5.12 Chile
- 12.5.13 South East Asia
- 12.5.14 Rest of Latin America
12.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 12.6.1 By Technology
- 12.6.2 By Application
- 12.6.3 By End-use
- 12.6.4 By Sequencing By Synthesis
- 12.6.5 By Sequencing By Ligation
- 12.6.6 By Product
- 12.6.7 By Route Of Administration
- 12.6.8 By Drugs
- 12.6.9 Saudi Arabia
- 12.6.10 UAE
- 12.6.11 Israel
- 12.6.12 South Africa
- 12.6.13 Rest of the Middle East And Africa

Chapter 13. COMPETITIVE LANDSCAPE

13.1. Recent Developments
13.2. Company Categorization
13.3. Supply Chain & Channel Partners (based on availability)
13.4. Market Share & Positioning Analysis (based on availability)
13.5. Vendor Landscape (based on availability)
13.6. Strategy Mapping

Chapter 14. COMPANY PROFILES OF GLOBAL PRECISION MEDICINE INDUSTRY

14.1. Top Companies Market Share Analysis
14.2. Company Profiles
- 14.2.1 Biocrates Life Sciences
- 14.2.2 Tepnel Pharma Services
- 14.2.3 Novartis
- 14.2.4 Qiagen
- 14.2.5 Quest Diagnostics
- 14.2.6 Menarini Silicon Biosystems
- 14.2.7 NanoString Technologies
- 14.2.8 Eagle Genomics
- 14.2.9 Pfizer
- 14.2.10 Intomics
- 14.2.11 Roche
- 14.2.12 Teva Pharmaceutical